JP2005518790A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005518790A5 JP2005518790A5 JP2003566246A JP2003566246A JP2005518790A5 JP 2005518790 A5 JP2005518790 A5 JP 2005518790A5 JP 2003566246 A JP2003566246 A JP 2003566246A JP 2003566246 A JP2003566246 A JP 2003566246A JP 2005518790 A5 JP2005518790 A5 JP 2005518790A5
- Authority
- JP
- Japan
- Prior art keywords
- chromosome
- translocation
- region
- cell lymphoma
- ctcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000349 chromosome Anatomy 0.000 claims 31
- 230000005945 translocation Effects 0.000 claims 24
- 201000005962 mycosis fungoides Diseases 0.000 claims 21
- 208000028561 Primary cutaneous T-cell lymphoma Diseases 0.000 claims 18
- 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 claims 18
- 201000007241 cutaneous T cell lymphoma Diseases 0.000 claims 18
- 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 claims 18
- 108090000623 proteins and genes Proteins 0.000 claims 16
- 238000000034 method Methods 0.000 claims 12
- 239000012634 fragment Substances 0.000 claims 9
- 208000035970 Chromosome Breakpoints Diseases 0.000 claims 7
- 230000007547 defect Effects 0.000 claims 7
- 238000012217 deletion Methods 0.000 claims 7
- 230000037430 deletion Effects 0.000 claims 7
- 102000004169 proteins and genes Human genes 0.000 claims 7
- 230000002759 chromosomal effect Effects 0.000 claims 6
- 230000001537 neural effect Effects 0.000 claims 6
- 239000012472 biological sample Substances 0.000 claims 5
- 239000003153 chemical reaction reagent Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 101100348015 Homo sapiens NAV3 gene Proteins 0.000 claims 2
- 101150026704 NAV3 gene Proteins 0.000 claims 2
- 238000011161 development Methods 0.000 claims 2
- 238000007901 in situ hybridization Methods 0.000 claims 2
- 238000011065 in-situ storage Methods 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 108020003215 DNA Probes Proteins 0.000 claims 1
- 239000003298 DNA probe Substances 0.000 claims 1
- 238000009007 Diagnostic Kit Methods 0.000 claims 1
- 102100030464 Neuron navigator 3 Human genes 0.000 claims 1
- 101710145274 Neuron navigator 3 Proteins 0.000 claims 1
- 208000009359 Sezary Syndrome Diseases 0.000 claims 1
- 208000021388 Sezary disease Diseases 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000002559 cytogenic effect Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 238000004043 dyeing Methods 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 238000010422 painting Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000011002 quantification Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
- 238000012360 testing method Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000009466 transformation Effects 0.000 claims 1
- 238000012800 visualization Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20020132 | 2002-01-24 | ||
| FI20020132A FI20020132A7 (fi) | 2002-01-24 | 2002-01-24 | Diagnostisia ja terapeuttisia menetelmiä |
| FI20021617A FI113666B (fi) | 2002-01-24 | 2002-09-10 | Menetelmiä, joissa käytetään kromosomin 12 spesifisiä katkoskohtia ja/tai neuroninavigaattori 3 -geeniä ihon primaaristen T-solulymfoomien diagnosoimiseksi ja taudin etenemisen seuraamiseksi tai ennustamiseksi, sekä näiden katkoskohtien ja geenien käyttö |
| FI20021617 | 2002-09-10 | ||
| PCT/FI2003/000061 WO2003066898A1 (en) | 2002-01-24 | 2003-01-24 | A method for the diagnosis of lymphoproliferative diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005518790A JP2005518790A (ja) | 2005-06-30 |
| JP2005518790A5 true JP2005518790A5 (enExample) | 2006-02-09 |
| JP4782378B2 JP4782378B2 (ja) | 2011-09-28 |
Family
ID=26161265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003566246A Expired - Fee Related JP4782378B2 (ja) | 2002-01-24 | 2003-01-24 | リンパ球異常増殖疾患の診断方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7803532B2 (enExample) |
| EP (1) | EP1476567A1 (enExample) |
| JP (1) | JP4782378B2 (enExample) |
| AU (1) | AU2003201630A1 (enExample) |
| CA (1) | CA2474446A1 (enExample) |
| FI (1) | FI113666B (enExample) |
| WO (1) | WO2003066898A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0878552A1 (en) | 1997-05-13 | 1998-11-18 | Erasmus Universiteit Rotterdam | Molecular detection of chromosome aberrations |
| CA2327542C (en) | 1998-05-04 | 2011-11-22 | Dako A/S | Method and probes for the detection of chromosome aberrations |
| WO2007071829A2 (en) * | 2005-12-22 | 2007-06-28 | Dermagene Oy | Methods and means related to diseases |
| AU2007321070B2 (en) * | 2006-11-13 | 2013-11-21 | Valipharma | Methods and uses involving genetic abnormalities at chromosome 12 |
| HRP20150373T1 (xx) | 2007-09-20 | 2015-07-03 | Valipharma | Dijagnostiäśke metode b-staniäśnog limfoma |
| WO2009126804A2 (en) * | 2008-04-11 | 2009-10-15 | The Regents Of The University Of Colorado, A Body Corporate | Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis |
| PL2350316T3 (pl) * | 2008-10-20 | 2014-10-31 | Valipharma | Sposoby i zastosowania obejmujące aberracje genetyczne NAV3 i nieprawidłową ekspresję wielu genów |
| WO2021061752A1 (en) * | 2019-09-23 | 2021-04-01 | Neonc Technologies, Inc. | Pharmaceutical compositions comprising poh derivatives |
| US20230057230A1 (en) | 2020-03-16 | 2023-02-23 | Mandom Corporation | Method for detecting indicator of t-cell lymphoma and utilization thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6007994A (en) * | 1995-12-22 | 1999-12-28 | Yale University | Multiparametric fluorescence in situ hybridization |
| HRP20150373T1 (xx) * | 2007-09-20 | 2015-07-03 | Valipharma | Dijagnostiäśke metode b-staniäśnog limfoma |
-
2002
- 2002-09-10 FI FI20021617A patent/FI113666B/fi not_active IP Right Cessation
-
2003
- 2003-01-24 WO PCT/FI2003/000061 patent/WO2003066898A1/en not_active Ceased
- 2003-01-24 US US10/502,638 patent/US7803532B2/en not_active Expired - Fee Related
- 2003-01-24 JP JP2003566246A patent/JP4782378B2/ja not_active Expired - Fee Related
- 2003-01-24 EP EP03700329A patent/EP1476567A1/en not_active Withdrawn
- 2003-01-24 CA CA 2474446 patent/CA2474446A1/en not_active Abandoned
- 2003-01-24 AU AU2003201630A patent/AU2003201630A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5032304B2 (ja) | 染色体異常の検出 | |
| JP7306723B2 (ja) | 遺伝子のｃｐｇメチル化変化を用いた肝癌の予後または危険度を評価する方法 | |
| CN101553577B (zh) | 快速基因分型分析和分析设备 | |
| Lubitz et al. | Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions | |
| ES2659798T3 (es) | Detección de la restricción de cadena ligera de inmunoglobulina por hibridación in situ de ARN | |
| CN112129736B (zh) | 粘蛋白和循环肿瘤细胞的均相可视化/荧光poct检测方法 | |
| CN102648291A (zh) | 用于诊断角膜营养不良的多点金属封端的纳米结构阵列核酸芯片及其制备方法 | |
| WO2019024404A1 (zh) | 用于检测胰腺癌的基因标志物、试剂盒及胰腺癌检测方法 | |
| KR101313756B1 (ko) | 간암 특이적 과메틸화 ＣｐＧ 서열을 이용한 간암의 검출방법 | |
| AU2025279660A1 (en) | Methods and compositions for the analysis of cancer biomarkers | |
| JP2005518790A5 (enExample) | ||
| Sornambikai et al. | CRISPR based biosensing: an ultrasensitive theranostic tool for the detection of early breast cancer biomarkers–a mini review | |
| US12275994B2 (en) | Methods and compositions for the analysis of cancer biomarkers | |
| JP7245164B2 (ja) | 高感度かつ定量的な遺伝子検査方法、プライマーセット、及び検査キット | |
| CN101298630A (zh) | 一种Solexa技术鉴定结肠癌病人血清中微小核糖核酸的方法 | |
| Hamada et al. | Diagnostic usefulness of PCR profiling of the differentially expressed marker genes in thyroid papillary carcinomas | |
| JP7540730B2 (ja) | 関節リウマチを検査する方法 | |
| KR20180081445A (ko) | 핵산의 신속 검출법 및 이를 이용한 질병의 신속 진단 방법 | |
| CN107988361A (zh) | 诊断子宫颈癌或评估子宫颈癌风险的方法和试剂盒 | |
| RU2468088C1 (ru) | Способ оценки эффективности терапии рака мочевого пузыря человека методом иммуноферментного анализа | |
| JP2022025456A (ja) | 多発性硬化症を検査する方法 | |
| CN119570930B (zh) | 生物标志物patj-dt在诊断或预后预测结直肠癌中的应用 | |
| CN119842908B (zh) | 一种用于宫颈癌和/或宫颈癌前病变检测的甲基化标志物组合及其应用、产品、检测装置、计算机可读存储介质、电子终端和计算机程序 | |
| CN120174092B (zh) | 检测甲基化标志物的物质在制备检测宫颈癌和/或宫颈癌前病变产品中的应用 | |
| WO2021060311A1 (ja) | 脳腫瘍を検査する方法 |